RA
Raphael Pharmaceutical Inc.
RAPH · OTC
$1.40 +0.00% (+$0.00)
Market Cap $28.2M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
1/9Valuation
-
N/A P/FCF N/A
P/E N/A
EV/FFO N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
57 /100
Average Asset turnover 0.00x
ROIC 50.33%
ROA 14,000.00%
Debt
0 /100
High Int. coverage -17.49x
Current ratio 0.00x
Debt/Assets N/A
Stability
1 /100
Unstable Profitable years 0
Beta 1.90x
EPS volatility 94.94%
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre RAPH
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Shlomo Pilo
Employees
0
Headquarters
Jaffa